Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koon Teo

Showing results (91-100 of 171) with videos related to

Pageof 18
Sort By:
Plos Medicine|September 16, 2024
Effectiveness and risk of ARB and ACEi among different ethnic groups in England: A reference trial (ONTARGET) emulation analysis using UK Clinical Practice Research Datalink Aurum-linked dataParis J Baptiste, Angel Y S Wong, Anna Schultze, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2023
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-AnalysisZeinab Bidel, Milad Nazarzadeh, Dexter Canoy, et al.
Journal of Cardiac Failure|April 22, 2004
The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristicsBarry M Massie, William F Krol, Susan E Ammon, et al.
American Journal of Epidemiology|June 19, 2024
Cardiorenal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET)Paris J Baptiste, Angel Y S Wong, Anna Schultze, et al.
Circulation|March 18, 2009
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trialBarry M Massie, Joseph F Collins, Susan E Ammon, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 30, 2008
Cardiovascular protection for all individuals at high risk: evidence-based best practiceGeorge Bakris, Michael Böhm, Gilles Dagenais, et al.
Plos One|December 21, 2010
Environmental Profile of a Community's Health (EPOCH): an instrument to measure environmental determinants of cardiovascular health in five countriesClara K Chow, Karen Lock, Manisha Madhavan, et al.
Stroke|June 14, 2014
Incidental magnetic resonance diffusion-weighted imaging-positive lesions are rare in neurologically asymptomatic community-dwelling adultsSaima Batool, Martin O'Donnell, Mukul Sharma, et al.
Lancet (London, England)|November 14, 2021
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysisMilad Nazarzadeh, Zeinab Bidel, Dexter Canoy, et al.
Hypertension (Dallas, Tex. : 1979)|January 14, 2015
Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular riskMichael Böhm, Helmut Schumacher, Darryl Leong, et al.
Pageof 18

Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Plos Medicine|September 16, 2024
Effectiveness and risk of ARB and ACEi among different ethnic groups in England: A reference trial (ONTARGET) emulation analysis using UK Clinical Practice Research Datalink Aurum-linked dataParis J Baptiste, Angel Y S Wong, Anna Schultze, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2023
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-AnalysisZeinab Bidel, Milad Nazarzadeh, Dexter Canoy, et al.
Journal of Cardiac Failure|April 22, 2004
The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristicsBarry M Massie, William F Krol, Susan E Ammon, et al.
American Journal of Epidemiology|June 19, 2024
Cardiorenal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET)Paris J Baptiste, Angel Y S Wong, Anna Schultze, et al.
Circulation|March 18, 2009
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trialBarry M Massie, Joseph F Collins, Susan E Ammon, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 30, 2008
Cardiovascular protection for all individuals at high risk: evidence-based best practiceGeorge Bakris, Michael Böhm, Gilles Dagenais, et al.
Plos One|December 21, 2010
Environmental Profile of a Community's Health (EPOCH): an instrument to measure environmental determinants of cardiovascular health in five countriesClara K Chow, Karen Lock, Manisha Madhavan, et al.
Stroke|June 14, 2014
Incidental magnetic resonance diffusion-weighted imaging-positive lesions are rare in neurologically asymptomatic community-dwelling adultsSaima Batool, Martin O'Donnell, Mukul Sharma, et al.
Lancet (London, England)|November 14, 2021
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysisMilad Nazarzadeh, Zeinab Bidel, Dexter Canoy, et al.
Hypertension (Dallas, Tex. : 1979)|January 14, 2015
Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular riskMichael Böhm, Helmut Schumacher, Darryl Leong, et al.
Pageof 18